spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Transcatheter Mitral Valve Replacement 

 HSMN NewsFeed - 31 Mar 2022
4C Medical Technologies Completes $35 Million Series C Financing and Appoints Saravana Kumar as President and CEO
Devices Cardiology Personnel Venture Capital
 HSMN NewsFeed - 27 Jan 2022
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 24 Sep 2020
InnovHeart Reports Successful First-in-Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2019
Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 21 Mar 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 22 Jan 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Sep 2018
InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 26 Jul 2018
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Jun 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
Devices Cardiology Personnel
 HSMN NewsFeed - 25 May 2018
Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2018
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2015
Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 9 Oct 2014
Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 May 2012
Micro Interventional Devices, Inc. Secures Bridge Financing to Advance Clinical Development of Permaseal(TM)
Devices Surgery Cardiology Venture Capital
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.